Aprepitant Oral Powder for Suspension shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Apr 8, 2026 · last update Apr 8, 2026
Manufacturers: Merck Sharp & Dohme LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03) | Merck Sharp & Dohme LLC | To Be Discontinued | — | To be discontinued in approximately early-September 2026. | Posted Apr 8, 2026 Updated Apr 8, 2026 Discontinued Apr 8, 2026 |